Search

Your search keyword '"Ntreta M"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Ntreta M" Remove constraint Author: "Ntreta M"
122 results on '"Ntreta M"'

Search Results

1. Intense surveillance for patients treated with radical prostatectomy and adverse pathologic features: early results from “easy-1 (early salvage radiotherapy-1) protocol”

2. PO-1474 Adjuvant radiotherapy of prostate cancer: a comprehensive analysis of toxicity predictors

4. PD-0566 MRI before salvage radiotherapy after radical prostatectomy in prostate cancer: a case-control study

5. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

6. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)

7. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

8. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

9. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

10. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

11. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

12. PO-1394 Stereotactic body radiotherapy for prostate cancer lymph node metastases: a systematic review

13. PO-1392 Salvage radiotherapy of prostate cancer: a risk stratification system based on prognostic factors

14. PO-1380 Adjuvant radiotherapy of prostate cancer: a risk stratification system based on prognostic factors

15. PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed?

16. PO-1391 Curative radiotherapy of prostate cancer: a risk stratification system based on prognostic factors

19. PD-0056: Factors predicting acute and late gastrointestinal and genitourinary toxicity in prostate cancer

20. PO-1185: Results of prostate cancer patients treated by integrated boost to dominant intraprostatic lesion

21. Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems

22. Radiotherapy of prostate cancer: Impact of treatment characteristics on the incidence of second tumors

23. EP-1561 Prostate cancer radiotherapy: a systematic review about boost on the dominant intraprostatic lesion

24. EP-1535 Vessel-sparing prostate V-MAT with simultaneous integrated boost to dominant intraprostatic lesion

25. Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study

26. EP-1561: A systematic review on postoperative hypofractionated radiation therapy in prostate carcinoma

27. PV-0622: Impact and efficacy of 68GA-PSMA PET/CT in recurrent prostate cancer patients with PSA < 0.5 ng/ml

28. EP-1560: Clinical results of a moderately hypofractionated radiotherapy in postoperative prostate carcinoma

29. EP-1562: Phase II“cima” trial on combined, intensified and modulated adjuvant radiotherapy in prostate cancer

30. PO-0914: Nerve-sparing prostate stereotactic ablative radiotherapy (SBRT) using SIB-VMAT technique

31. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study

32. Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial

34. Linea guida interna di terapia adiuvante e follow-up dopo chirurgia radicale per carcinoma prostatico

35. Stereotactic body radiotherapy for medically inoperable early stage non small cell lung cancer: a retrospective single-center experience

36. EP-1357: Moderately hypofractionated IGRT / IMRT-SIB in prostate carcinoma: toxicity and QoL in 300 patients

37. EP-1287: Radiation-induced rectal toxicity in prostate cancer: a proctoscopy evaluation

38. EP-1038: IMRT/VMAT-SIB technique chemoradiation in locally advanced head and neck cancer: toxicity results

39. EP-1355: Combined and modulated adjuvant therapy in prostate carcinoma: a phase I-II trial

40. EP-1348: Endoscopic evaluation of late rectal toxicity after radiotherapy in 597 prostate cancer patients

41. EP-1371: Role of 11C choline PET/CT in the management of prostate cancer patients with biochemical relapse

42. EP-1425: Phase I study on hypofractionated accelerated radiotherapy for bone metastases from prostate cancer

43. 2728 Electro-chemotherapy in recurrent vulvar cancer

49. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study

50. Radiotherapy of Prostate Carcinoma: A Comparison of the Predictive Role of EAU Versus NCCN Risk Stratification Systems

Catalog

Books, media, physical & digital resources